
The new prophylactic HPV vaccines consist of virus-like particles self-assembled from recombinantly expressed L1 major capsid protein. Due to the absence of potentially oncogenic viral DNA, they have been proven safe and well tolerated in thousands of vaccinated individuals. Prophylactic HPV vaccination has demonstrated 100% efficacy in preventing type-specific persistent infections and associated genital dysplasias.
Papillomavirus Infections, Virion, Uterine Cervical Neoplasms, Drug Design, Practice Guidelines as Topic, Humans, Female, Immunization, Papillomavirus Vaccines, Practice Patterns, Physicians'
Papillomavirus Infections, Virion, Uterine Cervical Neoplasms, Drug Design, Practice Guidelines as Topic, Humans, Female, Immunization, Papillomavirus Vaccines, Practice Patterns, Physicians'
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 4 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
